Clinical Trials Logo

Clinical Trial Details — Status: No longer available

Administrative data

NCT number NCT01435551
Other study ID # ALZ2012JB
Secondary ID
Status No longer available
Phase N/A
First received September 9, 2011
Last updated February 2, 2016

Study information

Verified date February 2016
Source Families To The Rescue
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Expanded Access

Clinical Trial Summary

From the past research that has been done the investigators have learned that brain cells die & leave a deposit in the brain known as beta-amyloid. Since alzheimer's is a slow acting disease the natural immune system does not respond to this illness so this builds up in the brain. As it builds up it gets into the neurotransmitters in the brain causing more brain cells to die. As these buildups occur dementia sets in due to more of the brain dying & effects normal activity.

STUDY WAS CANCELLED

Hypnotherapy will be used to do the following things:

- Increase the immune system

- The immune system will begin to clean up the beta-amyloid buildup

- That removes damage cells of the brain

- Increase more blood flow to the brain

- Allows the active brain cells to be trained to carry out daily activities

STUDY WAS CANCELLED


Description:

Hypnotherapy has been used for many things through the years. Today many doctors use it for their patients for operations when blood supply is low to control bleeding, pain for difficult dental work, mental issues & many other things.

Back in the 1950's a doctor Wilhelm Reich was able to increase the immune system & tested it by blood samples. The immune system isn't sending enough white blood cells into the brain to clean up beta-amyloids. Using hypnotherapy could increase the white blood cells to the brain to clean up the damage.

In theory the primitive part of the brain ( 1%)job is to protect the body from harm. It does this by giving out a fight or flight response to the subconscious mind which is (88%) of our brain. Then the conscious mind controls the body to either fight or flight. Since Alzheimer's is such a slow moving disease the primitive part of the brain does not react because of the slow action. So the subconscious never gets the message that there's a disease in the brain so the body could fight it off.

As the immune system cleans up the beta-amyloid buildup the healthy neurotransmitters are able to function. Healthy brain cells can be retrained so the quality of life can be more normal.

EXAMPLE:

* If you imagine driving down the same path across a field day after day. Before to long the grass dies & ruts start to form. Next thing you know your auto is hitting high center. So you have to move over to keep from getting stuck in the ruts. The brain works in the same way. The person do things without thinking because that is how the brain has been trained. But the brain can be retrained to do the functions as it did before the illness.

Hypnotherapy session will be:

- One hour long

- one session per month for 9 months

- 3 months free of any sessions to measure the effect

STUDY WAS CANCELLED


Recruitment information / eligibility

Status No longer available
Enrollment 0
Est. completion date
Est. primary completion date
Accepts healthy volunteers
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- Diagnosed having Alzheimer

- Under doctor's care

Exclusion Criteria:

- Must be able to follow instructions

Study Design

N/A


Related Conditions & MeSH terms


Intervention

Other:
Hypnotherapy
1 year study,1 hour session per month for 9 months, 3 remaining months evaluation

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Families To The Rescue
See also
  Status Clinical Trial Phase
Completed NCT04079803 - PTI-125 for Mild-to-moderate Alzheimer's Disease Patients Phase 2
Completed NCT04044495 - Sleep, Rhythms and Risk of Alzheimer's Disease N/A
Terminated NCT03052712 - Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies N/A
Recruiting NCT04520698 - Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease N/A
Active, not recruiting NCT04606420 - Can Lifestyle Changes Reverse Early-Stage Alzheimer's Disease N/A
Recruiting NCT05820919 - Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase N/A
Terminated NCT03672474 - REGEnLIFE RGn530 - Feasibility Pilot N/A
Completed NCT03430648 - Is Tau Protein Linked to Mobility Function?
Recruiting NCT04522739 - Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease Phase 4
Recruiting NCT05557409 - A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation Phase 3
Recruiting NCT04949750 - Efficacy of Paper-based Cognitive Training in Vietnamese Patients With Early Alzheimer's Disease N/A
Recruiting NCT05288842 - Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
Completed NCT06194552 - A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07 Phase 1
Completed NCT03239561 - Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants Early Phase 1
Completed NCT03184467 - Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients Phase 2
Active, not recruiting NCT03676881 - Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Terminated NCT03487380 - Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's Disease N/A
Completed NCT05538455 - Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases N/A
Recruiting NCT05328115 - A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease Phase 1
Completed NCT05562583 - SAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual Support N/A